Evidence-based selection of essential in vitro diagnostics, priority medical devices and assistive products to accelerate progress towards universal health coverage in the WHO African Region

Welcome! You are invited to a webinar, please Register now in advance. Following your registration, you will receive an email with a link that you can use to join the meeting.

When: August 21, 2021 10:00 a.m., Brazzaville, Republic of Congo (UTC / GMT +1)

Topic: Evidence-based selection of essential in vitro diagnostics, priority medical devices and assistive products to accelerate progress towards universal health coverage in the WHO African Region


We are delighted to announce a webinar organized by the regional clusters UHC / LC / MIM, ARD / DLS, EPR and in collaboration with WHO / HQ.

The webinar is aimed at medical device experts from WHO AFRO Member States from: ministries of health, policy makers, biomedical engineering departments, heads of national laboratory departments, national regulatory agencies, national technology centers health, national HTA agencies, universities, procurement agencies, program managers, standards organizations / authorities, NGOs, civil society organizations and UN agencies, including colleagues from the ‘WHO.

The working languages ​​will be French English and Portuguese with simultaneous translation available

For those who have not installed the Zoom platform on their computers, they are encouraged to do so before the meeting, so that they can participate fully.

register here

Meeting number: 948 2502 8533

Access code: S * tY $ 1in

Please note that the link is for registration only because when you register, the system will automatically generate a link that you will use to join the meeting.

Looking forward to your presence and your participation in the discussions.

Source link

About Catherine Sherrill

Check Also

Medical Device News: Latest medical device news, Indian medical device news and updates

There is smog in the air and it will continue for about a month. It …

Leave a Reply

Your email address will not be published. Required fields are marked *